NEXGEL names Ian Blackman as chief financial officer

NEXGEL, Inc. (NASDAQ: NXGL) announced the appointment of Ian Blackman as chief financial officer. The company manufactures hydrogel products for healthcare and consumer applications from its Langhorne, Pennsylvania location.

Blackman brings over 30 years of finance experience across publicly traded and private equity-backed organizations. He previously served as CFO at McIntosh Group, Inc., where the company reported revenue growth of over 90% and EBITDA increases of over 335% during his tenure. His background includes finance roles at luxury brands Diptyque and Trish McEvoy, as well as 16 years at Universal Music Group.

The appointment comes as NEXGEL works toward completing a definitive agreement to license and acquire regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU). Blackman will help advance the closing of this transaction and support integration planning for the acquisition.

"Ian's extensive experience scaling businesses, strengthening financial infrastructure, and navigating complex transactions makes him a timely and exceptional addition to our leadership team," said Adam Levy, NEXGEL's chief executive officer.

Blackman holds a bachelor's degree in Economics from the London School of Economics and began his career in audit at Goldstein Golub Kessler and Company. At McIntosh Group, he participated in two sale transactions before joining NEXGEL.

NEXGEL develops electron-beam, cross-linked hydrogels and operates brands including SilverSeal, Hexagels, Turfguard, Kenkoderm and Silly George. The company also maintains contract manufacturing relationships with consumer healthcare companies.

You May Also Be Interested In

• Moderna adds former Biogen CFO Michael McDonnell to its board
• Nocera agrees to acquire equity stake in energy storage firm INERGX
• LM Funding mines 8.7 Bitcoin in June amid heat-related efficiency drop